Results 201 to 206 of about 4,245 (206)

Six-years experience in the treatment of the neuroendocrine tumors with the use of peptide receptor radionuclide therapy (PRRT)

Endocrine Abstracts, 2013
Anna Sowa-Staszczak, Agnieszka Stefanska, Monika Tomaszuk, Aleksandra Gilis-Januszewska, Dorota Pach, Renata Mikolajczak, Alicja Hubalewska-Dydejczyk   +6 more
openaire   +1 more source

Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors

Thoracic Surgery Clinics, 2014
Lisa Bodei, Marta Cremonesi, Mark Kidd   +2 more
exaly  

Initial experience in establishing a national 177Lu peptide receptor radionuclide therapy (PRRT) service

Physica Medica
Ann McCann, Niamh McArdle, Nicola Hughes, Josh Nograles, Avril Mogan, Matthew Reade, Darragh McCague, Jackie McCavana   +7 more
openaire   +1 more source

Progress in the treatment of unresectable metastatic ileum-cecal NET - Peptide receptor radionuclide therapy (PRRT)

Endocrine Abstracts, 2019
Lia Terhes, Elena Baciu, Ana Curt, Raul Sazan, Tim Wollenweber, Cristian Brad, Carmen Georgescu, Ioana Ilie   +7 more
openaire   +1 more source

PS04.08 EXAMPLE OFWORKFLOWFOR INDIVIDUAL DOSIMETRY IN PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) WITH Lu-177

Physica Medica
A. Kubik, A. Budzynska, P. Pastusiak, K. Kacperski, M. Kołodziej, G. Kaminski, R. Mikolajczak   +6 more
openaire   +1 more source

Peptide Receptor Radionuclide Therapy (PRRT) for Treatment of Functional and Metastatic Phaeochromocytoma (PCC) and Paraganglioma (PGL)

2017
Kong, G., Grozinsky-Glasberg, S., Callahan, J., Hofman, M., Meirovitz, A., Maimon, O., Pattison, D., Gross, D., Hicks, R.   +8 more
openaire   +1 more source